Please Wait

Applying Filters...

Excipient Market Overview: Evonik launches high-purity excipients; India mandates disclosures from March 2026

Data Compilation
#PharmaFlow

Pipeline Prospector November 2025: Kimberly-Clark to buy Kenvue for US$ 48.7 bn; FDA approves Novartis’ gene therapy

Stock Recap
#PipelineProspector

Docetaxel, anhydrous

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

95 API Suppliers, 40 USDMF, 29 CEP/COS, 10 JDMF, 11 EU WC, 16 KDMF, 15 NDC API, 42 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

544 Drugs in Development

544 Drugs in Development

INTERMEDIATES

9 Intermediate Suppliers

9 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

379 FDF Dossiers, 87 FDA Orange Book, 174 Europe, 4 Canada, 8 Australia, 34 South Africa, 72 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - 160MG/8ML (20MG/ML), INJECTABLE;INJECTION - 20MG/ML (20MG/ML), INJECTABLE;INJECTION - 20MG/0.5ML (40MG/ML), INJECTABLE;INJECTION - 80MG/4ML (20MG/ML), INJECTABLE;INJECTION - 80MG/2ML (40MG/ML), INJECTABLE;INJECTION - 160MG/8ML (20MG/ML), INJECTABLE;INJECTION - 20MG/ML (20MG/ML), INJECTABLE;INJECTION - 40MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - 80MG/4ML (20MG/ML), INJECTABLE;INJECTION - 160MG/8ML (20MG/ML), INJECTABLE;INJECTION - 20MG/ML (20MG/ML), INJECTABLE;INJECTION - 80MG/4ML (20MG/ML), INJECTABLE;INJECTION - 20MG/VIAL, INJECTABLE;INJECTION - 80MG/VIAL

RELATED EXCIPIENT COMPANIES

1 Boai NKY Pharmaceuticals Ltd, 3 Nanjing Well Pharmaceutical, 3 Kirsch Pharma, 2 Actylis, 2 BASF, 1 CD Formulation, 1 Clariant, 1 Finar, 3 Gangwal Chemicals, 1 Nanjing Bold Chemical, 6 Seppic, 1 Valens Pharmachem

EXCIPIENTS BY APPLICATIONS

13 Solubilizers, 10 Parenteral, 7 Thickeners and Stabilizers, 7 Topical, 4 Surfactant & Foaming Agents, 4 Emulsifying Agents, 4 Film Formers & Plasticizers, 2 Rheology Modifiers, 1 Direct Compression, 1 Taste Masking, 1 Coating Systems & Additives, 1 API Stability Enhancers, 1 Co-Processed Excipients

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 1 Stock Recap #PipelineProspector, 144 News #PharmaBuzz

GLOBAL SALES INFORMATION

14 US Medicaid Prescriptions, 42 Regulatory FDF Prices, 7 Annual Reports

MARKET PLACE

15 APIs, 14 FDF Dossiers

PATENTS & EXCLUSIVITIES

44 US Patents, 8 Health Canada Patents

REF. STANDARDS & IMPURITIES

4 EDQM, 2 USP, 4 JP, 18 Others

$ Xls download

Filters

Log in to download the data

Last Updated on PharmaCompass	Virtual Booth	Country	Certificate Holder	Certificate No.	Substance	Issue Date	Status	Type	End Date	Substance No.
29/11/2025	Phyton Biotech LLC	Canada	PHYTON BIOTECH LLC Delta CA	R1-CEP 2012-105 - Rev 01	Docetaxel	2019-10-08	Valid	Chemical		2593
29/11/2025	Sanofi	France	SANOFI WINTHROP INDUSTRIE Gentilly FR	CEP 2009-343 - Rev 04	Docetaxel trihydrate	2024-03-28	Valid	Chemical		2449

Contact us
to update this info

Docetaxel, Anhydrous

Docetaxel, anhydrous

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

95 API Suppliers

40 USDMF

29 CEP/COS

10 JDMF

11 EU WC

16 KDMF

15 NDC API

42 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

544 Drugs in Development

INTERMEDIATES

9 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

379 FDF Dossiers

87 FDA Orange Book

174 Europe

4 Canada

8 Australia

34 South Africa

72 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - 160MG/8ML (20MG/ML)

INJECTABLE;INJECTION - 20MG/ML (20MG/ML)

INJECTABLE;INJECTION - 20MG/0.5ML (40MG/ML)

INJECTABLE;INJECTION - 80MG/4ML (20MG/ML)

INJECTABLE;INJECTION - 80MG/2ML (40MG/ML)

INJECTABLE;INJECTION - 160MG/8ML (20MG/ML)

INJECTABLE;INJECTION - 20MG/ML (20MG/ML)

INJECTABLE;INJECTION - 40MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - 80MG/4ML (20MG/ML)

INJECTABLE;INJECTION - 160MG/8ML (20MG/ML)

INJECTABLE;INJECTION - 20MG/ML (20MG/ML)

INJECTABLE;INJECTION - 80MG/4ML (20MG/ML)

INJECTABLE;INJECTION - 20MG/VIAL

INJECTABLE;INJECTION - 80MG/VIAL

RELATED EXCIPIENT COMPANIES

1 Boai NKY Pharmaceuticals Ltd

3 Nanjing Well Pharmaceutical

3 Kirsch Pharma

2 Actylis

2 BASF

1 CD Formulation

1 Clariant

1 Finar

3 Gangwal Chemicals

1 Nanjing Bold Chemical

6 Seppic

1 Valens Pharmachem

EXCIPIENTS BY APPLICATIONS

13 Solubilizers

10 Parenteral

7 Thickeners and Stabilizers

7 Topical

4 Surfactant & Foaming Agents

4 Emulsifying Agents

4 Film Formers & Plasticizers

2 Rheology Modifiers

1 Direct Compression

1 Taste Masking

1 Coating Systems & Additives

1 API Stability Enhancers

1 Co-Processed Excipients

DIGITAL CONTENT

1 Data Compilation #PharmaFlow

1 Stock Recap #PipelineProspector

144 News #PharmaBuzz

GLOBAL SALES INFORMATION

14 US Medicaid Prescriptions

42 Regulatory FDF Prices

7 Annual Reports

MARKET PLACE

15 APIs

INJECTABLE;INJECTION - 40MG/ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons